FBT vs. SGE, AVV, AVST, SOPH, KNOS, PRSM, KAPE, TRST, GBG, and ATG
Should you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include The Sage Group (SGE), AVEVA Group (AVV), Avast (AVST), Sophos Group plc (SOPH.L) (SOPH), Kainos Group (KNOS), Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), GB Group (GBG), and Auction Technology Group (ATG). These companies are all part of the "software - application" industry.
The Sage Group (LON:SGE) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk.
The Sage Group received 448 more outperform votes than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation when rated by MarketBeat users. However, 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote while only 44.87% of users gave The Sage Group an outperform vote.
The Sage Group presently has a consensus target price of GBX 1,108.33, suggesting a potential upside of 5.46%. Given First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's higher possible upside, analysts plainly believe The Sage Group is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.
The Sage Group has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than The Sage Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 0.00 equaled The Sage Group'saverage media sentiment score.
The Sage Group has a net margin of 11.87% compared to The Sage Group's net margin of 0.00%. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity of 22.31% beat The Sage Group's return on equity.
68.3% of The Sage Group shares are held by institutional investors. 0.7% of The Sage Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
The Sage Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 11 of the 13 factors compared between the two stocks.
Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically
Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List
Related Companies and Tools
